We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$160M
AUM Growth
+$10.8M
Cap. Flow
+$3.5M
Cap. Flow %
2.19%
Top 10 Hldgs %
22.6%
Holding
105
New
4
Increased
38
Reduced
27
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 17.25%
2 Technology 12.95%
3 Consumer Staples 10.6%
4 Financials 10.34%
5 Healthcare 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
51
Chevron
CVX
$382B
$1.24M 0.78%
11,089
-522
-4% -$59.3K
VTI icon
52
Vanguard Total Stock Market ETF
VTI
$657B
$1.24M 0.78%
11,680
MOS icon
53
The Mosaic Company
MOS
$7.27B
$1.19M 0.74%
26,045
-16,725
-39% -$741K
ADP icon
54
Automatic Data Processing
ADP
$110B
$1.1M 0.69%
13,248
-5,731
-30% -$464K
AMLP icon
55
Alerian MLP ETF
AMLP
$13B
$1.07M 0.67%
12,178
-1,412
-10% -$128K
POT
56
DELISTED
Potash Corp Of Saskatchewan
POT
$1.06M 0.67%
+30,170
New +$1.03M
IVV icon
57
iShares Core S&P 500 ETF
IVV
$873B
$1.06M 0.67%
5,135
+3,650
+246% +$739K
HD icon
58
Home Depot
HD
$341B
$1.04M 0.66%
9,960
PG icon
59
Procter & Gamble
PG
$338B
$975K 0.61%
10,707
-170
-2% -$15K
AOR icon
60
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.65B
$956K 0.6%
23,842
-40
-0.2% -$1.59K
IAU icon
61
iShares Gold Trust
IAU
$63.6B
$883K 0.55%
38,620
-2,065
-5% -$48K
EWC icon
62
iShares MSCI Canada ETF
EWC
$6.19B
$873K 0.55%
30,275
-6,930
-19% -$204K
OIH icon
63
VanEck Oil Services ETF
OIH
$2B
$841K 0.53%
1,172
-451
-28% -$375K
DUK icon
64
Duke Energy
DUK
$100B
$758K 0.48%
9,085
+300
+3% +$24.2K
AMJ
65
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$737K 0.46%
16,055
DIS icon
66
Walt Disney
DIS
$172B
$690K 0.43%
7,330
GWR
67
DELISTED
Genesee & Wyoming Inc.
GWR
$644K 0.4%
+7,171
New +$663K
BXP icon
68
Boston Properties
BXP
$11.9B
$628K 0.39%
4,885
DD
69
DELISTED
Du Pont De Nemours E I
DD
$556K 0.35%
7,929
+4,212
+113% +$282K
PFE icon
70
Pfizer
PFE
$144B
$544K 0.34%
18,426
IBM icon
71
IBM
IBM
$218B
$539K 0.34%
3,520
BMY icon
72
Bristol-Myers Squibb
BMY
$130B
$517K 0.32%
8,760
+2,500
+40% +$141K
CTAS icon
73
Cintas
CTAS
$87.4B
$508K 0.32%
25,916
JPM icon
74
JPMorgan Chase
JPM
$930B
$474K 0.3%
7,581
KMB icon
75
Kimberly-Clark
KMB
$37.5B
$450K 0.28%
3,900
-168
-4% -$18.6K

Similar funds

Boston Research & Management's Q4 2014 Portfolio in Review

As of Q4 2014, Boston Research & Management held 105 positions worth $160M, up 7.3% from $149M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management's Q4 2014 filing shows 4 new, 38 increased, 27 reduced and 2 closed positions. Its largest new stake was Potash Corp Of Saskatchewan: 30,170 shares worth $1.06M. The largest sale was The Mosaic Company, an estimated $741K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q4 2014 buy was Potash Corp Of Saskatchewan: 30,170 shares worth $1.06M.
  • Boston Research & Management added most to Vanguard FTSE All-World ex-US ETF in Q4 2014, an estimated $1.21M increase.
  • Boston Research & Management's biggest Q4 2014 reduction was The Mosaic Company, cutting an estimated $741K.
  • Boston Research & Management fully exited iShares Core MSCI Emerging Markets ETF in Q4 2014, selling an estimated $322K.
  • Boston Research & Management's ten largest holdings make up 23% of its $160M portfolio in Q4 2014.
  • Boston Research & Management opened 4 new positions and closed 2 in Q4 2014.
  • Boston Research & Management's portfolio value rose 7.3% quarter-over-quarter to $160M.

Based on Boston Research & Management's 13F filing for Q4 2014, filed 11 Feb 2015.